Orientation and Affiliation:

Shanghai Novopathway Biotechnology is affiliated with Beijing Sun-Novo Pharmaceutical Research and it set up in 2021. Our office is located in Zhang Jiang High Tech Park-Lin-Feng Technology Park.

As an innovation-driven, quality-based, and customer-focused CRO company, Novopathway

Biotechonology will commit to pre-clinical studies of antibody drugs’ R & D, small molecular R & D, cell and gene therapy, stem cell research or therapy, and clinical translational medical services for our global customers. Our platform will insist on global quality and efficient execution, which will accelerate the progress of drug development.

 i

Devices and Teams:

Our 3000 square meter primary facility has 6 floors of offices, an animal house and a laboratory. Our in vivo devices cover the FACS platform (BD Canto & Fetessa) and the Cytokine assay platform (MSD S600), the platform for small animal surgery (anesthesia machine and small animal brain) (locator), and there are Thermo CryoPlus Storage Systems, Olympus Biological Microscopes, and Countstar Rigel S3 for stem cell platform. We are also equipped with the SCIEX Triple Quad 5500+ systems, QX100 Droplet Digital PCR systems, M5 microplate reader, and PE multifu for ex-vivo platforms. The Clinical Center lab has a pathological staining machine and BD FACSCanto flow cytometry systems. Our core technical team has more than 10 years of service experience at a global top CRO, among which 44% have a doctor's degree and 87% have a master's degree or above.